Neumora Therapeutics (NMRA) Property, Plant & Equipment (Net) (2022 - 2026)
Neumora Therapeutics (NMRA) recorded Property, Plant & Equipment (Net) of $25,000 in Q2 2026, down 71.3% from $87,000 a year earlier and down 21.9% from the prior quarter.
Neumora Therapeutics (NMRA) Property, Plant & Equipment (Net) (2022 - 2026) Analysis & Trends
At the end of FY2025, Neumora Therapeutics reported Property, Plant & Equipment (Net) of $40,000, down 96.5% from FY2024.
- Annual Property, Plant & Equipment (Net) has declined for three straight years, with a three-year compound annual growth rate of -74.5% (FY2022 to FY2025).
- Across earlier years, Property, Plant & Equipment (Net) came in at $1.14 million in FY2024 (-36.3%), $1.79 million in FY2023 (-25.8%) and $2.41 million in FY2022.
- The Q2 2026 figure is the lowest quarterly Property, Plant & Equipment (Net) in data going back to Q4 2022.
- On a year-over-year basis, Property, Plant & Equipment (Net) has declined for eight consecutive quarters, with an average decline of 70.2% over the last eight quarters.
- Across the past five years, year-over-year decline in Property, Plant & Equipment (Net) ran from 25.8% in Q4 2023 to 96.7% in Q1 2026.
- Per Business Quant, the preceding three quarters came in at $32,000 (Q1 2026), $40,000 (Q4 2025) and $80,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 29.29 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 23.58 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 5.80 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 25.74 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 10.69 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 13.62 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 8.55 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 5.83 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 19.03 Bn |
| 10 | Neumora Therapeutics | 93.95 Mn | 93.95 Mn | - | 25,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25,000.00 |
| Mar 31, 2026 | 32,000.00 |
| Dec 31, 2025 | 40,000.00 |
| Sep 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 87,000.00 |
| Mar 31, 2025 | 982,000.00 |
| Dec 31, 2024 | 1.14 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.64 Mn |
| Dec 31, 2023 | 1.79 Mn |
| Sep 30, 2023 | 1.93 Mn |
| Dec 31, 2022 | 2.41 Mn |
Neumora Therapeutics Property, Plant & Equipment (Net) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=NMRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "property-plant-and-equipment-net", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();